Lataa...
Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer
RATIONALE: Recent studies have discovered several unique tumor response subgroups outside of response classification by Response Evaluation Criteria for Solid Tumors (RECIST), such as mixed response and oligometastasis. These subtypes have a distinctive property, lesion heterogeneity defined as dive...
Tallennettuna:
| Julkaisussa: | PLoS One |
|---|---|
| Päätekijät: | , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Public Library of Science
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8248740/ https://ncbi.nlm.nih.gov/pubmed/34197475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0252041 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|